Skip to product information
1 of 1

GeneBio Systems

Recombinant Human FABP3 Protein (His Tag)

Recombinant Human FABP3 Protein (His Tag)

SKU:PDEH100670

Regular price $1,017.00 USD
Regular price Sale price $1,017.00 USD
Sale Sold out
Shipping calculated at checkout.

Size:100μg

Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping:This product is provided as lyophilized powder which is shipped with ice packs.

Exp date:12 months

Category ID_II:Recombinant Proteins

Category ID_III:Others

Abbreviation:FABP3

Target Synonym:FABP11;FABP3;Fatty Acid-Binding Protein 3;Fatty Acid-Binding Protein Heart;H-FABP;Heart-Type Fatty Acid-Binding Protein;M-FABP;MDGI;MDGIMuscle Fatty Acid-Binding Protein;Mammary-Derived Growth Inhibitor;O-FABP

Research Areas:Cardiovascular;metabolism;Stem cells

Conjugation:

Target Species:Human

Expression Host:E.coli

Application:

Fusion tag:N-His

UNIProt ID:P05413

Accession:P05413

Background:Fatty Acid Binding Protein 3 (FABP3) is a small cytoplasmic protein (15 kDa) that is released from cardiac myocytes following an ischemic episode. Like the nine other distinct FABPs that have been identified, FABP3 is involved in active fatty acid metabolism where it transports fatty acids from the cell membrane to mitochondria for oxidation. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal-and cardiac-types. They form 14-15 kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. The FABP3 gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is also a candidate tumor suppressor gene for human breast cancer. FABP3 is a sensitive biomarker for myocardial infarction and can be detected in the blood within one to three hours of onset of pain.

Concentration:

Activity:Not validated for activity

Sequence:Val2-Ala133

Purity: > 95% as determined by reducing SDS-PAGE.

Formulation:Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.
Normally 5%-8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin:< 10 EU/mg of the protein as determined by the LAL method.

Calculated MW:17.0 kDa

ObservedMW:15 kDa

View full details